
Molecular and Cellular Technologies Lab (MCTL)
The lab mission is to develop molecular and cellular solutions addressing important challenges in biomedical science and clinical medicine, especially in the areas of imaging and diagnostics. We create small molecules, engineered proteins and cell-based tools that can "light up" and control in vivo biology using principles of chemical and synthetic biology. When possible, our technologies are translated to the clinic using nuclear medicine and molecular imaging techniques. For example, our group recently pioneered the development, preclinical testing, and human application of a new class of positron emission tomography (PET) radiotracers based on the small molecule antibiotic trimethoprim. These molecules have diverse applications in our broad fields of investigation including cancer biology, immunology, and infectious disease. If you have any questions about who we are and what we do, don't hesitate to reach out to us.
News
-
Wow -- things are heating up. So happy for Jean M. Etersque who received her NIH F31 Notice of Award today! Thanks… https://t.co/g4eNvvzejh
sellmyerlab 1 week, 4 days ago
-
RT @SNM_MI: #SNMMI Abstract Highlight: Molecular imaging biomarker predicts response to CAR T cell therapy.… https://t.co/kePGlF6e0n
sellmyerlab 2 weeks, 6 days ago
-
Award winning! Happy for Iris and Gabrielle! https://t.co/99i5vXco3R
sellmyerlab 3 weeks, 2 days ago